Tumour-selective drug delivery via folate receptor-targeted liposomes
Authors:
- 1 November 2004
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 1 (1) , 7-17
Abstract
Tumour cell-targeted liposomal delivery has the potential to enhance the therapeutic efficacy and reduce the toxicity of anticancer agents. Folate receptor (FR) expression is frequently amplified among human malignancies. FR is, therefore, potentially useful as a tumour marker for targeted drug delivery. FR-mediated liposomal delivery has been shown to enhance the antitumour efficacy of doxorubicin both in vitro and in vivo, and to overcome P-glycoprotein-mediated multi-drug resistance. In addition, FR-targeted liposomes have shown utility as effective delivery vehicles of genes and antisense oligodeoxyribonucleotides to FR(+) tumour cells. Both solid tumours and leukaemias can potentially benefit from FR-targeted drug delivery. Multiple mechanisms might contribute to greater therapeutic efficacy for FR-targeted liposomes, such as FR-dependent cytotoxicity and antiangiogenic activity. Further investigation of this promising drug delivery strategy is clearly warranted.Keywords
This publication has 63 references indexed in Scilit:
- Folate-mediated delivery of macromolecular anticancer therapeutic agentsAdvanced Drug Delivery Reviews, 2002
- Folate receptor-targeted liposomes as vectors for therapeutic agents2002
- Targeted drug delivery via the folate receptorAdvanced Drug Delivery Reviews, 2000
- Polyethylenglykol-umhülltes (pegyliertes) liposomales DoxorubicinDrugs, 1997
- Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.Proceedings of the National Academy of Sciences, 1995
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Cationic liposome-mediated transfectionNature, 1989
- Cell-specific drug transfer from liposomes bearing monoclonal antibodiesNature, 1981
- p H-Sensitive Liposomes: Possible Clinical ImplicationsScience, 1980
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965